Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate Models

Mario Roederer1

  • 1ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

Plos Pathogens
|August 19, 2015
PubMed

Related Concept Videos